Press Room

ISySyCat21

Start
Tuesday, August 31, 2021 - 09:00
End
Friday, September 03, 2021 - 09:00
Location: Evora, Portugal
ISySyCat21 - Hovione gold sponsor catalysis

Hovione is present at the International Symposium on Synthesis and Catalysis 2021 (ISySyCat2021) taking place at the University of Evora in the historically recognized mediaeval city of Evora from August 31st to September 3rd 2021.

The conference will be a mixed event, in person to be hold in Evora, Portugal (with a limited number of participants) and on-line (webinar). 

The conference will focus on key topics in contemporary organic, organometallic, polymer synthesis and catalysis, which are of relevance to both academic and industrial chemists alike. This is reflected in the topics that will be discussed in the plenary lectures.

 

 

Hovione will present a topic at the plenary lectures with the following details:

 

Natural potential: biocatalyzed asymmetric synthesis of chiral amines

The presentation will address the screening and optimization of biocatalysts for the synthesis of chiral amines of interest in the manufacture of APIs.

Presenter: Ágnes Lakó
Date: 31st August
Time: 3:15 pm - 3:30 pm

 

Also in the Press Room

See All

Lisbon, Portugal – Hovione, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, Hovione joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At Hovione, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of Hovione. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” Hovione will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with Hovione’s sustainability ambitions.  Hovione remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024